We are live on ! Find out more
IDNA icon

iShares Genomics Immunology and Healthcare ETF
IDNA

60 hedge funds and large institutions have $61.8M invested in iShares Genomics Immunology and Healthcare ETF in 2026 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 6

46% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 13

12% more capital invested

Capital invested by funds: $55M → $61.8M (+$6.8M)

3% more funds holding

Funds holding: 58 → 60 (+2)

0.81% less ownership

Funds ownership: 41.71% → 40.91% (-0.81%)

Holders
60
Holders Change
+2
Holders Change %
+3.45%
% of All Funds
0.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
19
Reduced
13
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$3.25M
2
Morgan Stanley
Morgan Stanley
New York
+$920K
3
SPIA
Steward Partners Investment Advisory
New York
+$685K
4
GS
GTS Securities
New York
+$676K
5
Ameriprise
Ameriprise
Minnesota
+$408K

Top Sellers

Rank Fund Capital Flow
1
Raymond James Financial
Raymond James Financial
Florida
-$1.85M
2
Jane Street
Jane Street
New York
-$1.37M
3
FTUS
Flow Traders U.S.
New York
-$1.08M
4
OC
Opal Capital
Florida
-$604K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$331K
Name Holding Trade Value Shares
Change 		Change in
Stake
FHC
26
First Heartland Consultants
Missouri
$238K -$15.3K -526 -6%
OIA
27
OneDigital Investment Advisors
Kansas
$228K – – –
BS
28
Banco Santander
Spain
$220K +$219K +7,560 New
M
29
MATAURO
New York
$215K +$215K +7,417 New
AIA
30
Ally Invest Advisors
North Carolina
$214K -$27.1K -935 -11%
Goldman Sachs
31
Goldman Sachs
New York
$209K +$208K +7,182 New
Rockefeller Capital Management
32
Rockefeller Capital Management
New York
$101K +$33.9K +1,168 +50%
FFA
33
Founders Financial Alliance
North Carolina
$99.1K – – –
Fifth Third Bancorp
34
Fifth Third Bancorp
Ohio
$41.1K +$41K +1,413 New
T
35
Tidemark
California
$40.4K -$232 -8 -0.6%
SS
36
Sunbelt Securities
Texas
$29.1K – – –
TCM
37
Triumph Capital Management
Colorado
$26.6K -$10K -346 -27%
VR
38
Vision Retirement
New Jersey
$21.8K – – –
PCFFS
39
Pacific Center for Financial Services
California
$16.1K +$87 +3 +0.5%
PNC Financial Services Group
40
PNC Financial Services Group
Pennsylvania
$16K +$13.1K +450 +450%
Northwestern Mutual Wealth Management
41
Northwestern Mutual Wealth Management
Wisconsin
$14.5K -$581 -20 -4%
FDCDDQ
42
Federation des caisses Desjardins du Quebec
Quebec, Canada
$8.71K – – –
Qube Research & Technologies (QRT)
43
Qube Research & Technologies (QRT)
United Kingdom
$8.57K -$1.02K -35 -11%
IA
44
IFP Advisors
Florida
$8.45K – – –
National Bank of Canada
45
National Bank of Canada
Quebec, Canada
$8.28K +$8.3K +286 New
MMCM
46
Murphy & Mullick Capital Management
New York
$7.99K – – –
FFA
47
Farther Finance Advisors
California
$7.5K – – –
AIC
48
Archer Investment Corporation
Indiana
$7.2K – – –
CWMS
49
CFG Wealth Management Services
Indiana
$5.81K – – –
PA
50
Parallel Advisors
California
$5.81K – – –
1
2
3

IDNA Hedge Fund Activity: Q1 2026 in Review

60 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q1 2026, worth a combined $61.8M — up 12% from $55M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new IDNA positions and 6 closed out — a net gain of 3 holders — while 19 added to existing stakes and 13 trimmed.

The largest buyer was Bank of America, adding an estimated $3.25M. The largest seller was Raymond James Financial, cutting an estimated $1.85M.

  • 60 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q1 2026, up from 58 in Q4 2025.
  • Funds reported $61.8M of iShares Genomics Immunology and Healthcare ETF stock for Q1 2026, up 12% quarter-over-quarter.
  • 9 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q1 2026 and 6 closed out, a net change of +3 holders.
  • The largest iShares Genomics Immunology and Healthcare ETF buyer in Q1 2026 was Bank of America, an estimated $3.25M added.
  • The largest iShares Genomics Immunology and Healthcare ETF seller in Q1 2026 was Raymond James Financial, an estimated $1.85M sold.

Based on aggregated 13F filings for Q1 2026.